Literature DB >> 11344244

Extrathyroidal manifestations of Graves' disease: the thyrotropin receptor is expressed in extraocular, but not cardiac, muscle tissues.

B E Busuttil1, A G Frauman.   

Abstract

The existence of an autoantigen common to Graves' disease and its associated extrathyroidal manifestations has been proposed. As the TSH receptor (TSHR) is the primary target for autoimmunity against the thyroid in Graves' disease, much effort has gone into investigating the role of TSHR messenger ribonucleic acid (mRNA) transcripts in extrathyroidal tissue, particularly in the orbit. A high stringency RT-PCR technique had previously been employed by our laboratory to demonstrate the presence of full-length and splice variant TSHR mRNA in extraocular muscle (EOM). This technique demonstrated selective amplification of TSHR mRNA transcripts in thyroid and EOM, but not in abdominal muscle, kidney, or brain tissue. We used this technique in the present study to investigate the reported presence of TSHR mRNA transcripts in cardiac tissue. After removal of all visible fat from muscle tissues, high stringency RT-PCR was performed, and we found no TSHR transcripts in the muscle of any chamber of the normal human heart. In addition, in situ hybridization on fresh-frozen and paraffin-embedded sections confirmed the presence of TSHR transcripts in thyroid and EOM, but not in abdominal or cardiac muscle. These findings support the hypothesis that the TSHR is a shared antigen in the thyroid and EOM, but not in cardiac muscle.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11344244     DOI: 10.1210/jcem.86.5.7474

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  18 in total

1.  Fibroblasts expressing the thyrotropin receptor overarch thyroid and orbit in Graves' disease.

Authors:  Terry J Smith; Dolly A Padovani-Claudio; Ying Lu; Nupur Raychaudhuri; Roshini Fernando; Stephen Atkins; Erin F Gillespie; Andrew G Gianoukakis; Barbra S Miller; Paul G Gauger; Gerard M Doherty; Raymond S Douglas
Journal:  J Clin Endocrinol Metab       Date:  2011-09-28       Impact factor: 5.958

2.  Antibodies targeting the calcium binding skeletal muscle protein calsequestrin are specific markers of ophthalmopathy and sensitive indicators of ocular myopathy in patients with Graves' disease.

Authors:  B Gopinath; R Musselman; N Beard; S El-Kaissi; J Tani; C-L Adams; J R Wall
Journal:  Clin Exp Immunol       Date:  2006-07       Impact factor: 4.330

Review 3.  Current concepts in the molecular pathogenesis of thyroid-associated ophthalmopathy.

Authors:  Yao Wang; Terry J Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-03-20       Impact factor: 4.799

Review 4.  Psychiatric manifestations of Graves' hyperthyroidism: pathophysiology and treatment options.

Authors:  Robertas Bunevicius; Arthur J Prange
Journal:  CNS Drugs       Date:  2006       Impact factor: 5.749

5.  Quantification of cells expressing the thyrotropin receptor in extraocular muscles in thyroid associated orbitopathy.

Authors:  A Boschi; Ch Daumerie; M Spiritus; C Beguin; M Senou; D Yuksel; M Duplicy; S Costagliola; M Ludgate; M C Many
Journal:  Br J Ophthalmol       Date:  2005-06       Impact factor: 4.638

Review 6.  Cardiovascular involvement in patients with different causes of hyperthyroidism.

Authors:  Bernadette Biondi; George J Kahaly
Journal:  Nat Rev Endocrinol       Date:  2010-06-29       Impact factor: 43.330

7.  Mutations that silence constitutive signaling activity in the allosteric ligand-binding site of the thyrotropin receptor.

Authors:  Ann-Karin Haas; Gunnar Kleinau; Inna Hoyer; Susanne Neumann; Jens Furkert; Claudia Rutz; Ralf Schülein; Marvin C Gershengorn; Gerd Krause
Journal:  Cell Mol Life Sci       Date:  2010-07-22       Impact factor: 9.261

8.  Pathogenesis of thyroid-associated ophthalmopathy: does autoimmunity against calsequestrin and collagen XIII play a role?

Authors:  Hooshang Lahooti; Kishan R Parmar; Jack R Wall
Journal:  Clin Ophthalmol       Date:  2010-05-14

9.  Thyroid associated orbitopathy following periocular surgery.

Authors:  Sang June Kim; Byoung Jin Kim; Ha Bum Lee; Angelo Tsirbas; Michael Kazim
Journal:  Korean J Ophthalmol       Date:  2006-06

10.  Role of nucleostemin in growth regulation of gastric cancer, liver cancer and other malignancies.

Authors:  Si-Jin Liu; Zi-Wei Cai; Ya-Jun Liu; Mei-Yu Dong; Li-Qiu Sun; Guo-Fa Hu; Ying-Yun Wei; Wei-De Lao
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.